Caroline Block

599 total citations
25 papers, 273 citations indexed

About

Caroline Block is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Genetics. According to data from OpenAlex, Caroline Block has authored 25 papers receiving a total of 273 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 7 papers in Pulmonary and Respiratory Medicine and 6 papers in Genetics. Recurrent topics in Caroline Block's work include Breast Cancer Treatment Studies (6 papers), Advanced Breast Cancer Therapies (5 papers) and BRCA gene mutations in cancer (4 papers). Caroline Block is often cited by papers focused on Breast Cancer Treatment Studies (6 papers), Advanced Breast Cancer Therapies (5 papers) and BRCA gene mutations in cancer (4 papers). Caroline Block collaborates with scholars based in United States, Switzerland and Italy. Caroline Block's co-authors include Brian Drohan, Elissa M. Ozanne, Kevin S. Hughes, Alan Semine, Michael S. Jellinek, Michael A. Caligiuri, Thomas R. Klumpp, Robert J. Soiffer, Patrick Y. Wen and Jerome Ritz and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Cancer.

In The Last Decade

Caroline Block

23 papers receiving 257 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Caroline Block United States 10 108 104 55 54 54 25 273
Karenza Alexis United States 9 181 1.7× 57 0.5× 42 0.8× 55 1.0× 19 0.4× 16 317
Kristín Bjarnadóttir Iceland 5 166 1.5× 54 0.5× 61 1.1× 82 1.5× 42 0.8× 8 335
WM Gregory United Kingdom 9 195 1.8× 53 0.5× 90 1.6× 101 1.9× 61 1.1× 16 317
Clara Lam United States 8 127 1.2× 36 0.3× 35 0.6× 30 0.6× 50 0.9× 20 339
Chia Kee‐Seng Denmark 5 152 1.4× 110 1.1× 61 1.1× 89 1.6× 96 1.8× 5 405
A. Mitchell United Kingdom 8 147 1.4× 25 0.2× 97 1.8× 140 2.6× 57 1.1× 15 290
Malek M. Safa United States 9 125 1.2× 108 1.0× 102 1.9× 91 1.7× 31 0.6× 26 357
Offiong F. Ikpatt United States 10 176 1.6× 43 0.4× 101 1.8× 91 1.7× 21 0.4× 27 367
Seon-Hee Yim South Korea 9 130 1.2× 51 0.5× 26 0.5× 49 0.9× 50 0.9× 11 306
Ergin Bengisu Türkiye 9 33 0.3× 89 0.9× 25 0.5× 18 0.3× 56 1.0× 25 373

Countries citing papers authored by Caroline Block

Since Specialization
Citations

This map shows the geographic impact of Caroline Block's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Caroline Block with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Caroline Block more than expected).

Fields of papers citing papers by Caroline Block

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Caroline Block. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Caroline Block. The network helps show where Caroline Block may publish in the future.

Co-authorship network of co-authors of Caroline Block

This figure shows the co-authorship network connecting the top 25 collaborators of Caroline Block. A scholar is included among the top collaborators of Caroline Block based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Caroline Block. Caroline Block is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Weiss, Anna, Qingchun Jin, Nabihah Tayob, et al.. (2025). Axillary Management and Outcomes After Neoadjuvant Endocrine Therapy in the Randomized PELOPS Trial. Annals of Surgical Oncology. 33(3). 2275–2283.
2.
Hirko, Kelly A., Faina Nakhlis, Jennifer R. Bellon, et al.. (2024). Abstract PO1-09-10: County-level Social Vulnerability and Survival among Women with Inflammatory Breast Cancer. Cancer Research. 84(9_Supplement). PO1–9. 1 indexed citations
3.
4.
5.
Garrido-Castro, Ana C., Meredith M. Regan, Samuel M. Niman, et al.. (2023). Clinical outcomes of de novo metastatic HER2-positive inflammatory breast cancer. npj Breast Cancer. 9(1). 50–50. 4 indexed citations
6.
Morganti, Stefania, Brittany Bychkovsky, Philip D. Poorvu, et al.. (2023). Adjuvant Olaparib for Germline BRCA Carriers With HER2-Negative Early Breast Cancer: Evidence and Controversies. The Oncologist. 28(7). 565–574. 5 indexed citations
7.
Chen, Angela, et al.. (2023). Implementing a high-reliability, system-wide program for pre-emptive DPD deficiency testing for patients planned for a systemic fluoropyrimidine.. JCO Oncology Practice. 19(11_suppl). 396–396. 1 indexed citations
8.
Lu, Weidong, Anita Giobbie‐Hurder, Im Hee Shin, et al.. (2022). Auricular Acupuncture During Chemotherapy Infusion in Breast Cancer Patients: A Feasibility Study. Journal of Integrative and Complementary Medicine. 28(5). 427–435. 1 indexed citations
9.
Hirko, Kelly A., Meredith M. Regan, Beth Harrison, et al.. (2021). Dermal Lymphatic Invasion, Survival, and Time to Recurrence or Progression in Inflammatory Breast Cancer. American Journal of Clinical Oncology. 44(9). 449–455. 2 indexed citations
10.
Freedman, Rachel A., Mina S. Sedrak, Jennifer R. Bellon, et al.. (2020). Weathering the Storm: Managing Older Adults With Breast Cancer Amid COVID-19 and Beyond. JNCI Journal of the National Cancer Institute. 113(4). 355–359. 10 indexed citations
11.
Warren, Laura, Faina Nakhlis, Jennifer M. Rosenbluth, et al.. (2020). Characteristics associated with inflammatory breast cancer (IBC): An epidemiologic study from a dedicated IBC program. The Breast Journal. 26(9). 1688–1694. 7 indexed citations
12.
Plichta, Jennifer K., et al.. (2016). Application of the 2015 American Cancer Society screening mammography guidelines: Risk assessment for women ages 40-44.. Journal of Clinical Oncology. 34(15_suppl). 1557–1557. 1 indexed citations
13.
Ruddy, Kathryn J., Stephen DeSantis, William T. Barry, et al.. (2014). Extended Therapy With Letrozole and Ovarian Suppression in Premenopausal Patients With Breast Cancer After Tamoxifen. Clinical Breast Cancer. 14(6). 413–416. 12 indexed citations
14.
Polubriaginof, Fernanda, Brian Drohan, Alan Semine, et al.. (2014). Implications of following the guidelines for genetic testing and MRI use for breast cancer.. Journal of Clinical Oncology. 32(15_suppl). 1549–1549. 1 indexed citations
15.
Reddy, Prabashni, Jean M. Connors, Gregory Piazza, et al.. (2011). Dabigatran. Critical Pathways in Cardiology A Journal of Evidence-Based Medicine. 10(3). 117–127. 11 indexed citations
16.
Ozanne, Elissa M., Christine Lawrence, Brian Drohan, et al.. (2009). Identification and Management of Women at High Risk for Hereditary Breast/Ovarian Cancer Syndrome. The Breast Journal. 15(2). 155–162. 45 indexed citations
17.
Talcott, James A., Paul C. Stomper, Frank W. Drislane, et al.. (1999). Assessing suspected spinal cord compression. Supportive Care in Cancer. 7(1). 31–38. 13 indexed citations
18.
Kantoff, Philip W., et al.. (1993). 14-Day Continuous Infusion of Mitoxantrone in Hormone-Refractory Metastatic Adenocarcinoma of the Prostate. American Journal of Clinical Oncology. 16(6). 489–491. 19 indexed citations
19.
Klumpp, Thomas R., et al.. (1992). Immune-Mediated Cytopenia following Bone Marrow Transplantation Case Reports and Review of the Literature. Medicine. 71(2). 73–83. 35 indexed citations
20.
Wen, Patrick Y., Kerry Blanchard, Caroline Block, et al.. (1992). Development of Lhermitte's sign after bone marrow transplantation. Cancer. 69(9). 2262–2266. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Karenza Alexis Breakdown of academic impact, for papers by Kristín Bjarnadóttir Breakdown of academic impact, for papers by WM Gregory Breakdown of academic impact, for papers by Clara Lam Breakdown of academic impact, for papers by Chia Kee‐Seng Breakdown of academic impact, for papers by A. Mitchell Breakdown of academic impact, for papers by Malek M. Safa Breakdown of academic impact, for papers by Offiong F. Ikpatt Breakdown of academic impact, for papers by Seon-Hee Yim Breakdown of academic impact, for papers by Ergin Bengisu
Rankless by CCL
2026